Progeria: a perspective on potential drug targets and treatment strategies

被引：2
|
作者：
Benedicto, Ignacio [1 ]
Chen, Xue [2 ]
Bergo, Martin O. [3 ]
Andres, Vicente [1 ,4 ]
机构：
[1] Ctr Nacl Invest Cardiovasc Carlos III CNIC, New Mech Atherosclerosis Program, Madrid, Spain
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Plast & Cosmet Surg, Wuhan, Huazhong, Peoples R China
[3] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden
[4] CIBER Enfermedades Cardiovasc CIBERCV, Madrid, Spain
来源：
EXPERT OPINION ON THERAPEUTIC TARGETS | 2022年 / 26卷 / 05期
基金：
瑞典研究理事会;
关键词：
Hutchinson-Gilford progeria syndrome; farnesyltransferase (FTase); isoprenylcysteine carboxyl methyltransferase (ICMT); antisense oligonucleotide (ASO); gene editing; CRISPR/Cas9; adenine base editor (ABE); THERAPEUTIC ANTISENSE OLIGONUCLEOTIDES; MOUSE MODEL; FARNESYLTRANSFERASE INHIBITOR; FARNESYLATION INHIBITORS; VASCULAR CALCIFICATION; EXTENDS LONGEVITY; CLINICAL-TRIAL; DISEASE; ACTIVATION; PRELAMIN;
D O I：
10.1080/14728222.2022.2078699
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：393 / 399
页数：7
相关论文
共 50 条
  • [1] Potential drug targets and treatment of schizophrenia
    Kumar, Anil
    Yadav, Monu
    Parle, Milind
    Dhingra, Sameer
    Dhull, Dinesh K.
    INFLAMMOPHARMACOLOGY, 2017, 25 (03) : 277 - 292
  • [2] Potential drug targets and treatment of schizophrenia
    Anil Kumar
    Monu Yadav
    Milind Parle
    Sameer Dhingra
    Dinesh K. Dhull
    Inflammopharmacology, 2017, 25 : 277 - 292
  • [3] Strategies and potential molecular targets for obesity treatment
    Campfield, LA
    Smith, FJ
    Burn, P
    SCIENCE, 1998, 280 (5368) : 1383 - 1387
  • [4] Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia
    Nikiforuk, Agnieszka
    CURRENT PHARMACEUTICAL DESIGN, 2016, 22 (14) : 2093 - 2116
  • [5] Identification of Potential Drug Targets for the Treatment of Severe Burn Wounds from a Multi-Omics Perspective
    Zhu, Gehua
    Li, Jiaqi
    Xu, Jiamin
    Guo, Guanghua
    Zhu, Feng
    JOURNAL OF INFLAMMATION RESEARCH, 2024, 17 : 11275 - 11289
  • [6] The proteomics bottleneck: strategies for preliminary validation of potential biomarkers and drug targets
    Bodovitz, S
    Joos, T
    TRENDS IN BIOTECHNOLOGY, 2004, 22 (01) : 4 - 7
  • [7] An Insight into the Current Perspective and Potential Drug Targets for Visceral Leishmaniasis (VL)
    Mansuri, Rani
    Singh, Jagbir
    Diwan, Anupama
    CURRENT DRUG TARGETS, 2020, 21 (11) : 1105 - 1129
  • [8] Gene Editing has Potential as Treatment for Progeria
    不详
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2021, 185 (03) : 671 - 672
  • [9] Metabotropic Glutamate Receptors: Potential Drug Targets for the Treatment of Schizophrenia
    Chavez-Noriega, Laura E.
    Schaffhauser, Herve
    Campbell, Una C.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (03) : 261 - 281
  • [10] Inflammation and Immune Regulation as Potential Drug Targets in Antidepressant Treatment
    Schmidt, Frank M.
    Kirkby, Kenneth C.
    Lichtblau, Nicole
    CURRENT NEUROPHARMACOLOGY, 2016, 14 (07) : 674 - 687
12345